Faeth Therapeutics

Develops oral cancer drug candidates targeting multiple nodes in the PI3K/AKT/mTOR pathway

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

About Faeth Therapeutics

Faeth Therapeutics develops investigational cancer therapies. Its lead program, PIKTOR, is an oral combination designed to inhibit PI3K-alpha, mTORC1 and mTORC2; its pipeline includes programs for endometrial and breast cancer.

The company was co-founded in 2019 by Anand Parikh and Oliver Maddocks, alongside cancer biologists. PIKTOR entered a Phase 2 endometrial cancer study in 2025, and the company reports a Phase 1b breast cancer program.

In February 2026, Faeth was acquired by Sensei Biotherapeutics, and PIKTOR became the combined company's lead program. Current openings include engineering, HR, contracts and regulatory operations roles.

Product: PIKTOR, an investigational oral combination therapy targeting multiple nodes of the PI3K/AKT/mTOR pathway.

Jobs at Faeth Therapeutics

No open positions listed right now.

More biotech & pharma companies

  • Fieldstone Bio

    Biological mineral sensing and mapping tools for mining exploration and operations teams
    United StatesBiotech & pharma
    New on Evolc
  • Forge Biologics

    AAV gene therapy development and manufacturing services for biotechnology companies and gene therapy developers
    United StatesBiotech & pharma
    New on Evolc
  • Formation Bio

    AI-driven pharmaceutical company acquiring and developing clinical-stage drugs to bring treatments to patients faster
    United StatesBiotech & pharma
    New on Evolc
  • Fractyl Health

    Develops endoscopic and gene therapies that target root causes of obesity and type 2 diabetes
    United StatesBiotech & pharma
    New on Evolc
  • Freenome

    Develops blood-based, multiomics cancer screening tests for early detection in patients and healthcare providers
    United StatesBiotech & pharma
    New on Evolc
  • Frontier Medicines

    Covalent small-molecule drug discovery for patients with diseases involving difficult-to-drug protein targets
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Frontend frameworks

  • Next.jsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • ReactMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Recruiting

  • GreenhouseMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.